PT Royal Prima Tbk (PRIM.JK)
IDR 57.0
(0.0%)
IDR 57.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 265.33 Billion IDR | 1.3% |
| 2022 | 261.93 Billion IDR | -56.34% |
| 2021 | 599.96 Billion IDR | 130.23% |
| 2020 | 260.59 Billion IDR | 49.58% |
| 2019 | 174.21 Billion IDR | -14.93% |
| 2018 | 204.79 Billion IDR | 15.32% |
| 2017 | 177.59 Billion IDR | 28.77% |
| 2016 | 137.92 Billion IDR | 89.62% |
| 2015 | 72.73 Billion IDR | 336.79% |
| 2014 | 16.65 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 69.24 Billion IDR | 3.01% |
| 2024 Q3 | 81.17 Billion IDR | 17.23% |
| 2024 Q1 | 67.22 Billion IDR | -16.22% |
| 2023 Q4 | 80.24 Billion IDR | 15.9% |
| 2023 FY | 265.33 Billion IDR | 1.3% |
| 2023 Q1 | 56.92 Billion IDR | -10.05% |
| 2023 Q3 | 69.23 Billion IDR | 17.49% |
| 2023 Q2 | 58.93 Billion IDR | 3.52% |
| 2022 Q1 | 79.36 Billion IDR | -6.86% |
| 2022 Q3 | 51.3 Billion IDR | -24.52% |
| 2022 Q4 | 63.28 Billion IDR | 23.35% |
| 2022 FY | 261.93 Billion IDR | -56.34% |
| 2022 Q2 | 67.97 Billion IDR | -14.36% |
| 2021 FY | 599.96 Billion IDR | 130.23% |
| 2021 Q1 | 96.11 Billion IDR | -7.88% |
| 2021 Q2 | 187.12 Billion IDR | 94.69% |
| 2021 Q3 | 231.51 Billion IDR | 23.72% |
| 2021 Q4 | 85.21 Billion IDR | -63.19% |
| 2020 Q3 | 73.41 Billion IDR | 97.43% |
| 2020 Q2 | 37.18 Billion IDR | -18.56% |
| 2020 Q1 | 45.65 Billion IDR | -6.44% |
| 2020 FY | 260.59 Billion IDR | 49.58% |
| 2020 Q4 | 104.33 Billion IDR | 42.13% |
| 2019 Q1 | 38.87 Billion IDR | -23.16% |
| 2019 FY | 174.21 Billion IDR | -14.93% |
| 2019 Q4 | 48.79 Billion IDR | 4.95% |
| 2019 Q3 | 46.49 Billion IDR | 16.1% |
| 2019 Q2 | 40.04 Billion IDR | 3.03% |
| 2018 FY | 204.79 Billion IDR | 15.32% |
| 2018 Q1 | 48.53 Billion IDR | 14.86% |
| 2018 Q2 | 47.59 Billion IDR | -1.93% |
| 2018 Q3 | 58.07 Billion IDR | 22.02% |
| 2018 Q4 | 50.58 Billion IDR | -12.9% |
| 2017 Q1 | 40.12 Billion IDR | 0.0% |
| 2017 Q4 | 42.25 Billion IDR | -23.29% |
| 2017 Q2 | 40.12 Billion IDR | 0.0% |
| 2017 Q3 | 55.08 Billion IDR | 37.29% |
| 2017 FY | 177.59 Billion IDR | 28.77% |
| 2016 FY | 137.92 Billion IDR | 89.62% |
| 2015 FY | 72.73 Billion IDR | 336.79% |
| 2014 FY | 16.65 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Bundamedik Tbk | 1488.19 Billion IDR | 82.171% |
| PT Metro Healthcare Indonesia Tbk | 242.68 Billion IDR | -9.336% |
| PT Medikaloka Hermina Tbk | 5784.08 Billion IDR | 95.413% |
| PT Mitra Keluarga Karyasehat Tbk | 4264.27 Billion IDR | 93.778% |
| PT Murni Sadar Tbk | 921.91 Billion IDR | 71.219% |
| PT Famon Awal Bros Sedaya Tbk | 1839.23 Billion IDR | 85.574% |
| PT Kedoya Adyaraya Tbk | 373.39 Billion IDR | 28.94% |
| PT Sarana Meditama Metropolitan Tbk | 1535.63 Billion IDR | 82.721% |
| PT Siloam International Hospitals Tbk | 11190.51 Billion IDR | 97.629% |
| PT Sejahteraraya Anugrahjaya Tbk | 2503.17 Billion IDR | 89.4% |